RMTI Rockwell Medical Inc

Price (delayed)

$1.97

Market cap

$59.72M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.36

Enterprise value

$67.26M

Rockwell Medical is a biopharmaceutical company dedicated to transforming anemia management in a wide variety of therapeutic areas and across the globe, improving the lives of very sick patients. The ...

Highlights
The EPS has soared by 56% YoY and by 2.7% from the previous quarter
The net income has increased by 37% YoY
RMTI's equity has surged by 65% year-on-year but it is down by 3% since the previous quarter
The company's debt fell by 8% YoY but it rose by 6% QoQ
RMTI's quick ratio is down by 13% YoY

Key stats

What are the main financial stats of RMTI
Market
Shares outstanding
30.32M
Market cap
$59.72M
Enterprise value
$67.26M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.8
Price to sales (P/S)
0.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.78
Earnings
Revenue
$86.62M
EBIT
-$6.08M
EBITDA
-$2.2M
Free cash flow
-$8.19M
Per share
EPS
-$0.36
Free cash flow per share
-$0.28
Book value per share
$0.7
Revenue per share
$2.95
TBVPS
$1.34
Balance sheet
Total assets
$50.72M
Total liabilities
$30.08M
Debt
$14.18M
Equity
$20.64M
Working capital
$11.75M
Liquidity
Debt to equity
0.69
Current ratio
1.79
Quick ratio
1.32
Net debt/EBITDA
-3.42
Margins
EBITDA margin
-2.5%
Gross margin
10.6%
Net margin
-9.7%
Operating margin
-7.6%
Efficiency
Return on assets
-17.4%
Return on equity
-46.1%
Return on invested capital
-21.4%
Return on capital employed
-17%
Return on sales
-7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

RMTI stock price

How has the Rockwell Medical stock price performed over time
Intraday
1.03%
1 week
-5.29%
1 month
7.07%
1 year
-51.12%
YTD
4.23%
QTD
11.93%

Financial performance

How have Rockwell Medical's revenue and profit performed over time
Revenue
$86.62M
Gross profit
$9.17M
Operating income
-$6.57M
Net income
-$8.42M
Gross margin
10.6%
Net margin
-9.7%
The company's operating margin has surged by 50% YoY and by 5% QoQ
The company's net margin rose by 44% YoY and by 4% QoQ
Rockwell Medical's operating income has increased by 43% YoY
The net income has increased by 37% YoY

Growth

What is Rockwell Medical's growth rate over time

Valuation

What is Rockwell Medical stock price valuation
P/E
N/A
P/B
2.8
P/S
0.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.78
The EPS has soared by 56% YoY and by 2.7% from the previous quarter
RMTI's equity has surged by 65% year-on-year but it is down by 3% since the previous quarter
RMTI's price to book (P/B) is 40% lower than its 5-year quarterly average of 4.6 and 29% lower than its last 4 quarters average of 3.9
RMTI's price to sales (P/S) is 45% lower than its 5-year quarterly average of 1.2 and 18% lower than its last 4 quarters average of 0.8
Rockwell Medical's revenue has increased by 13% YoY and by 3.6% from the previous quarter

Efficiency

How efficient is Rockwell Medical business performance
The ROS has soared by 53% YoY and by 4.1% from the previous quarter
RMTI's return on equity is up by 45% year-on-year and by 11% since the previous quarter
The return on invested capital has increased by 35% year-on-year and by 3.6% since the previous quarter
Rockwell Medical's return on assets has increased by 34% YoY and by 5% QoQ

Dividends

What is RMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RMTI.

Financial health

How did Rockwell Medical financials performed over time
Rockwell Medical's total assets is 69% more than its total liabilities
Rockwell Medical's total assets has increased by 25% YoY but it has decreased by 2.8% from the previous quarter
RMTI's quick ratio is down by 13% YoY
The company's debt is 31% lower than its equity
RMTI's equity has surged by 65% year-on-year but it is down by 3% since the previous quarter
The debt to equity has contracted by 44% YoY but it has grown by 10% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.